Woodline Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$703K Sell
2,806
-7,282
-72% -$1.81M ﹤0.01% 923
2025
Q4
$2.78M Sell
10,088
-242,128
-96% -$66.2M 0.01% 732
2025
Q3
$66.2M Buy
+252,216
New +$61.3M 0.31% 67
2025
Q2
Sell
-138,871
Closed -$31.1M 1064
2025
Q1
$31.1M Buy
138,871
+119,417
+614% +$32.9M 0.2% 154
2024
Q4
$6.37M Buy
+19,454
New +$6.12M 0.04% 438
2024
Q2
Sell
-166,588
Closed -$65.9M 689
2024
Q1
$65.9M Buy
166,588
+147,018
+751% +$54.4M 0.61% 39
2023
Q4
$6.89M Buy
+19,570
New +$6.93M 0.07% 273
2023
Q2
Sell
-81,725
Closed -$28.3M 764
2023
Q1
$28.3M Buy
81,725
+32,453
+66% +$9.48M 0.39% 78
2022
Q4
$11.6M Buy
+49,272
New +$11.7M 0.16% 186
2021
Q1
Sell
-33,980
Closed -$9.63M 480
2020
Q4
$9.63M Buy
+33,980
New +$9.54M 0.26% 118

Other funds holding WST